High-viscosity dietary fibers reduce adiposity and decrease hepatic steatosis in rats fed a high-fat diet

Journal of Nutrition

Volumn 144, Issue 9, 2014, Pages 1415-1422

  Brockman, David A ^a   Chen, Xiaoli ^a   Gallaher, Daniel D ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CARNITINE PALMITOYLTRANSFERASE I; CARNITINE PALMITOYLTRANSFERASE I BETA; CELLULOSE; CYTOCHROME C OXIDASE; FATTY ACID; FATTY ACID SYNTHASE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 43; GLUCOSE 6 PHOSPHATASE; GLYCOSYLATED HEMOGLOBIN; GUAR GUM; HYDROXYPROPYLMETHYLCELLULOSE; INSULIN; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG; FAT INTAKE; GALACTAN; MANNAN; PLANT GUM;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CALORIC INTAKE; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DIETARY FIBER; DISEASE COURSE; ENERGY EXPENDITURE; ENERGY YIELD; EPIDIDYMIS FAT; EXPERIMENTAL OBESITY; FAT MASS; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FATTY LIVER; FEEDING; FOOD DEPRIVATION; FOOD INTAKE; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN TOLERANCE TEST; LEAN BODY WEIGHT; LIPID DIET; LIPID LIVER LEVEL; LIVER WEIGHT; MALE; NONHUMAN; POSTPRANDIAL STATE; RAT; RESPIRATORY QUOTIENT; VISCOSITY; ANIMAL; CARBOHYDRATE METABOLISM; DISEASE MODEL; DRUG EFFECTS; FAT INTAKE; FERMENTATION; LIVER; METABOLISM; MUSCLE; OBESITY; PHARMACOLOGY; THERAPEUTIC USE; WISTAR RAT;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; CARBOHYDRATE METABOLISM; CELLULOSE; DIET, HIGH-FAT; DIETARY FATS; DIETARY FIBER; DISEASE MODELS, ANIMAL; FATTY ACIDS; FATTY LIVER; FERMENTATION; GALACTANS; HYPROMELLOSE DERIVATIVES; LIVER; MALE; MANNANS; MUSCLES; OBESITY; PLANT GUMS; RATS, WISTAR; VISCOSITY;

EID: 84906903396     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.114.191577     Document Type: Article

References (59)

1. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011;378:815-25.
2. Gastaldelli A, Harrison S, Belfort-Aguiar R, Hardies J, Balas B, Schenker S, Cusi K. Pioglitazone in the treatment of NASH: the role of adiponectin. Aliment Pharmacol Ther 2010;32:769-75.
3. Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 2000;49:677-83.
4. Corpeleijn E, Mensink M, Kooi ME, Roekaerts PM, Saris WH, Blaak EE. Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss. Obesity (Silver Spring) 2008;16:1025-32.
5. Bergouignan A, Antoun E, Momken I, Schoeller DA, Gauquelin-Koch G, Simon C, Blanc S. Effect of contrasted levels of habitual physical activity on metabolic flexibility. J Appl Physiol 2013;114:371-9.
6. Liu S, Willett WC, Manson JE, Hu FB, Rosner B, Colditz G. Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr 2003;78:920-7.
7. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med 2007;167: 956-65.
8. Weickert MO, Pfeiffer AF. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr 2008;138:439-42.
9. Kim M. High-methoxyl pectin has greater enhancing effect on glucose uptake in intestinal perfused rats. Nutrition 2005;21:372-7.
10. Hung SC, Anderson WH, Albers DR, Langhorst ML, Young SA. Effect of hydroxypropyl methylcellulose on obesity and glucose metabolism in a diet-induced obesity mouse model. J Diabetes 2011;3:158-67.
11. Isken F, Klaus S, Petzke KJ, Loddenkemper C, Pfeiffer AF, Weickert MO. Impairment of fat oxidation under high- vs. low-glycemic index diet occurs before the development of an obese phenotype. Am J Physiol Endocrinol Metab 2010;298:E287-95.
12. Reeves PG, Nielsen FH, Fahey GC, Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-51.
13. Peterson DA, Frank DN, Pace NR, Gordon JI. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 2008;3:417-27.
14. Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, Gill SR. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 2013;57:601-9.
15. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509.
16. Gallaher DD, Hassel CA, Lee KJ, Gallaher CM. Viscosity and fermentability as attributes of dietary fiber responsible for the hypocholesterolemic effect in hamsters. J Nutr 1993;123:244-52.
17. Monsma CC, Gallaher DD, Ney DM. Reduced digestibility of beef tallow and cocoa butter affects bile acid excretion and reduces hepatic esterified cholesterol in rats. J Nutr 1996;126:2028-35.
18. Lee SC, Prosky L, Devries JW. Determination of total, soluble, and insoluble dietary fiber in foods-Enzymatic Gravimetric Method, Mes- Tris Buffer Collaborative Study. J AOAC Int 1992;75:395-416.
19. Prosky L, Asp NG, Schweizer TF, DeVries JW, Furda I, Lee SC. Determination of soluble dietary fiber in foods and food products: collaborative study. J AOAC Int 1994;77:690-4.
20. Archer WL. Hansen solubility parameters for selected cellulose ether derivatives and their use in the pharmaceutical industry. Drug Dev Ind Pharm 1992;18:599-616.
21. Ong KT, Mashek MT, Bu SY, Mashek DG. Hepatic ATGL knockdown uncouples glucose intolerance from liver TAG accumulation. FASEB J 2013;27:313-21.
22. Teske JA, Perez-Leighton CE, Billington CJ, Kotz CM. Role of the locus coeruleus in enhanced orexin A-induced spontaneous physical activity in obesity-resistant rats. Am J Physiol Regul Integr Comp Physiol 2013;305: R1337-45.
23. McLean JA, Tobin G. Animal and human calorimetry. Cambridge, UK: Cambridge University Press; 1987.
24. Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C, Galloway JA, Frank BH, Karrison T, Van Cauter E. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 1988;81:435-41.
25. Hu FB, Chen C, Wang B, Stampfer MJ, Xu X. Leptin concentrations in relation to overall adiposity, fat distribution, and blood pressure in a rural Chinese population. Int J Obes Relat Metab Disord 2001;25:121-5.
26. Marciani L, Gowland PA, Spiller RC, Manoj P, Moore RJ, Young P, Al- Sahab S, Bush D, Wright J, Fillery-Travis AJ. Gastric response to increased meal viscosity assessed by echo-planar magnetic resonance imaging in humans. J Nutr 2000;130:122-7.
27. Lin PH, Shih BL, Hsu JC. Effects of different sources of dietary non-starch polysaccharides on the growth performance, development of digestive tract and activities of pancreatic enzymes in goslings. Br Poult Sci 2010;51:270-7.
28. Islam A, Civitarese AE, Hesslink RL, Gallaher DD. Viscous dietary fiber reduces adiposity and plasma leptin and increases muscle expression of fat oxidation genes in rats. Obesity (Silver Spring) 2012;20:349-55.
29. Hung SC, Bartley G, Young SA, Albers DR, Dielman DR, Anderson WH, Yokoyama W. Dietary fiber improves lipid homeostasis and modulates adipocytokines in hamsters. J Diabetes 2009;1:194-206.
30. Henningsson AM, Bjorck IM, Nyman EM. Combinations of indigestible carbohydrates affect short-chain fatty acid formation in the hindgut of rats. J Nutr 2002;132:3098-104.
31. Maki KC, Carson ML, Miller MP, Turowski M, Bell M, Wilder DM, Reeves MS. High-viscosity hydroxypropylmethylcellulose blunts postprandial glucose and insulin responses. Diabetes Care 2007;30:1039-43.
32. Jenkins DJ, Leeds AR, Gassull MA, Cochet B, Alberti GM. Decrease in postprandial insulin and glucose concentrations by guar and pectin. Ann Intern Med 1977;86:20-3.
33. Maki KC, Carson ML, Miller MP, Turowski M, Bell M, Wilder DM, Rains TM, Reeves MS. Hydroxypropylmethylcellulose and methylcellulose consumption reduce postprandial insulinemia in overweight and obese men and women. J Nutr 2008;138:292-6.
34. Sierra M, Garcia JJ, Fernandez N, Diez MJ, Calle AP, Sahagun AM. Effects of ispaghula husk and guar gum on postprandial glucose and insulin concentrations in healthy subjects. Eur J Clin Nutr 2001;55:235-43.
35. Bayliss CE, Houston AP. The effect of guar gum on microbial activity in the human colon. Food Microbiol 1985;2:53-62.
36. Chen HL, Haack VS, Janecky CW, Vollendorf NW, Marlett JA. Mechanisms by which wheat bran and oat bran increase stool weight in humans. Am J Clin Nutr 1998;68:711-9.
37. Burnier P, Tappy L, Jequier E, Schneeberger D, Chiolero R. Metabolic and respiratory effects of infused sodium acetate in healthy human subjects. Am J Physiol 1992;263:R1271-6.
38. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 2003;278:11312-9.
39. Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen JL, Tian H, Li Y. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 2008;149:4519-26.
40. Reimer RA, Grover GJ, Koetzner L, Gahler RJ, Lyon MR, Wood S. The soluble fiber complex PolyGlycopleX lowers serum triglycerides and reduces hepatic steatosis in high-sucrose-fed rats. Nutr Res 2011; 31:296-301.
41. Choi JS, Kim H, Jung MH, Hong S, Song J. Consumption of barley beta-glucan ameliorates fatty liver and insulin resistance in mice fed a high-fat diet. Mol Nutr Food Res 2010;54:1004-13.
42. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002;23:201-29.
43. Jensen-Urstad AP, Semenkovich CF. Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger? Biochim Biophys Acta 2012;1821:747-53.
44. Koo SH. Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. Clin Mol Hepatol 2013;19:210-5.
45. Ferr´e P, Foufelle F. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 2010;12 (Suppl 2):83-92.
46. Havula E, Hietakangas V. Glucose sensing by ChREBP/MondoA-Mlx transcription factors. Semin Cell Dev Biol 2012;23:640-7.
47. Barrows BR, Parks EJ. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J Clin Endocrinol Metab 2006;91:1446-52.
48. Targher G, Bertolini L, Scala L, Poli F, Zenari L, Falezza G. Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals. Clin Endocrinol (Oxf) 2004;61:700-3.
49. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP activated protein kinase. Nat Med 2002;8:1288-95.
50. Henao-Mejia J, Elinav E, Thaiss CA, Flavell RA. The intestinal microbiota in chronic liver disease. Adv Immunol 2013;117:73-97.
51. Brockman DA, Chen X, Gallaher DD. Hydroxypropyl methylcellulose, a viscous soluble fiber, reduces insulin resistance and decreases fatty liver in Zucker diabetic fatty rats. Nutr Metab (Lond) 2012;9:100.
52. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 1999;277:E1130-41.
53. Grover GJ, Koetzner L, Wicks J, Gahler RJ, Lyon MR, Reimer RA, Wood S. Effects of the soluble fiber complex PolyGlycopleX(R) (PGX (R)) on glycemic control, insulin secretion, and GLP-1 levels in Zucker diabetic rats. Life Sci 2011;88:392-9.
54. Færch K, Vaag A. Metabolic inflexibility is a common feature of impaired fasting glycaemia and impaired glucose tolerance. Acta Diabetol 2011;48:349-53.
55. Ukropcova B, Sereda O, de Jonge L, Bogacka I, Nguyen T, Xie H, Bray GA, Smith SR. Family history of diabetes links impaired substrate switching and reduced mitochondrial content in skeletal muscle. Diabetes 2007;56:720-7.
56. Chomentowski P, Coen PM, Radikova Z, Goodpaster BH, Toledo FG. Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility. J Clin Endocrinol Metab 2011;96:494-503.
57. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002; 51:2944-50.
58. Galgani JE, Heilbronn LK, Azuma K, Kelley DE, Albu JB, Pi-Sunyer X, Smith SR, Ravussin E. Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate. Diabetes 2008;57:841-5.
59. Asterholm IW, Scherer PE. Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol 2010;176:1364-76.